skyline-CCG-Full-Color-watermark-background-e1547842118849.png
Skyline Corporate Communications Group, LLC President, Scott Powell, Named by Business Insider Magazine as one of the Nation’s Top 18 Public Relations Executives
27 sept. 2023 08h00 HE | Skyline Corporate Communications Group, LLC
New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Skyline Corporate Communications Group, LLC, a consulting agency that provides customized corporate communications and strategic investor relations...
Logo.png
Ohmyhome Ltd. Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
27 juin 2023 09h45 HE | Ohmyhome Ltd.
SINGAPORE, June 27, 2023 (GLOBE NEWSWIRE) -- Ohmyhome Limited (“Ohmyhome” or the Company) (NASDAQ: OMH), a data-driven property technology company based in Singapore, today announced it has retained...
CTMnew
Castellum, Inc. Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
04 nov. 2022 06h55 HE | Castellum, Inc.
POTOMAC, Md., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (“Castellum” or the “Company”) (NYSE American: CTM), a cybersecurity, electronic warfare, data analytics, software, and IT services...
Logo.png
Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference
31 août 2022 08h00 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
15 août 2022 08h05 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
01 juin 2022 18h05 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...